Poor medication adherence tends to be a matter of people not taking their medicine as prescribed, due to access barriers. So how can placing an additional burden on patients be the answer?
The New York Times profiled the success story of a type 1 diabetes patient who was dosed with Vertex Pharmaceuticals’ experimental fully differentiated pancreatic islet cell replacement therapy, and after an infusion of VX-880, he began to produce his own insulin.
The Centers for Medicare & Medicaid Services (CMS) announced that ClosedLoop.ai was selected the winner and Geisinger the runner-up in the agency’s Artificial Intelligence Health Outcomes Challenge.
Mayo Clinic launched two new tech venture companies designed to harness artificial intelligence (AI) and medical algorithms and create “software as medical devices” that clinicians can use to improve treatment across different diseases.
MJH Life Sciences officially launched Medical World News, a first-of-its-kind 24-hour news program offering insights on the latest news in health care.
The blood glucose monitoring and data management company AgaMatrix and the digital health assistant developer LifeWallet announced a collaboration to bring AgaMatrix’s connected blood glucose monitoring solutions together with LifeWallet’s apps for health risk assessment and follow-up care, for improved outcomes in population health management.